CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Figure 5c and S4E clearly demonstrate that IM, LDN and DOR lead to a reduction in CML CD34+ cells, with the biggest reduction observed following DOR, IM + LDN and IM + DOR treatment.